WellCycle · Collaboration Brief

Built for Clinical
Collaboration.

WellCycle is a women’s health screening platform powered by 16+ on-device AI models. Everything runs on the user’s phone — no internet required, no health data uploaded. We are looking for clinical partners who can help us validate, refine, and expand its reach.

16+ Health Screenings
100% On-Device
Private Encrypted
0 MB Health Data Uploaded
The Platform

What We Built

Architecture

On-Device AI. No Cloud. No Compromise.

All health screenings run entirely on the user’s Android phone using proprietary on-device AI. No internet connection is required. Health data is end-to-end encrypted and never leaves the device — not to our servers, not to anyone.

  • Conditions screened — PCOS, endometriosis, menstrual irregularity, bone health, mental health, fibroids, thyroid, anaemia, and more. Models fire with age-appropriate gating logic.
  • Passive background screening — the engine scans as users log cycles, symptoms, wearable readings, and medications. High-confidence findings surface as prioritised clinical alerts.
  • Biometric security — fingerprint or face ID required on every launch. Data is inaccessible without the device keystore key.
  • Live on the Play Store — WellCycle is available now, free to download on any Android 8.0+ device. No subscription required for core screening.
The Problem

India’s Women’s Health Screening Gap

An estimated 1 in 5 Indian women lives with an undiagnosed reproductive or hormonal condition. Most existing tools require a hospital visit, a lab test, or a reliable internet connection.

  • Women in tier-2 and tier-3 cities and rural districts have no accessible early-warning pathway for conditions like PCOS or endometriosis — which are typically diagnosed 7–10 years after symptoms begin.
  • Women on long-term medications often develop secondary effects — menstrual disruption, hormonal imbalance, bone density loss — that go unmonitored because no single tool tracks them together.
  • WellCycle works entirely offline. Any Android phone becomes a private, clinical-grade screening device — no hospital visit, no lab, no internet required.
Where It Connects

Clinical Touchpoints

We are not reshaping WellCycle for any one specialty. These intersections exist naturally in the clinical data our models are built on.

Medication & Menstrual Health

Long-term medications frequently cause menstrual irregularity and bone density changes. WellCycle tracks both, surfacing signals a patient might not connect to their medication.

Offline-First, Rural-Ready

Full AI inference with zero connectivity. Designed for exactly the same underserved populations that community health outreach programmes reach.

Patient Self-Monitoring

Women log symptoms daily — the same philosophy as a clinical symptom diary, applied to hormonal health. Longitudinal patterns surface what point-in-time consultations miss.

Bone Health Screening

A dedicated AI screening module detects early markers of bone density loss — relevant wherever long-term medication use and nutritional deficiency overlap in the patient population.

What We Are Looking For

The Collaboration

WellCycle is built and live. What it needs now is structured clinical feedback and the credibility that comes from working alongside experienced clinicians.

  • Clinical feedback — does what the app surfaces match what a clinician would want a patient to act on? We want to calibrate our alert thresholds against real clinical judgment.
  • Pilot access — a defined group of patients using WellCycle and reporting back. We provide the app, the onboarding, and the analysis. No patient data is shared with us — feedback is qualitative.
  • Network introductions — access to the clinical community for broader validation, peer review of our model methodology, and eventual publication of outcomes.
Foundation Collaboration

Community health camps already reach thousands of women in underserved areas each year. We believe WellCycle could complement that work — giving women a free, private, take-home screening tool after a camp visit, so early-warning continues beyond the camp day itself.

We are open to exploring a formal collaboration on a pilot basis. If the results are there, a deeper partnership structure can follow naturally from that. We would rather let the clinical outcomes make the case than move ahead of them.

Ready to Talk?

Let’s Build Something Together.

Whether it’s a pilot, a clinical advisory role, or an exploratory conversation — we’re ready to listen and move at whatever pace works for you.

Prajas Labs Private Limited  ·  Andhra Pradesh, India  ·  CIN: U62099AP2026PTC126173

Confidential · Prajas Labs · July 2026